Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, against SARS-CoV-2 Challenge in Nonhuman Primates - Awasthi, Mayanka; Macaluso, Anthony; Myscofski, Dawn; Prigge, Jon; Koide, Fusataka; Noyce, Ryan S.; Fogarty, Siobhan; Stillwell, Helen; Goebel, Scott J.; Daugherty, Bruce; Nasar, Farooq; Bavari, Sina; et al. (Vaccines (Basel), 2023)
Keywords: Antibodies; Catheters; COVID-19; Cytokines; Dosage and administration; Effectiveness; Enzymes; horsepox virus; Immunogenetics; Immunogenicity; Immunoglobulin G; Infections; Laboratory animals; Lymphocytes T; Monkeys & apes; Primates; Proteins; Respiratory tract; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Smallpox vaccine; spike protein; Testing; TNX-1800; vaccine; vaccine platform; Vaccines; Viruses; γ-Interferon; United States; United States--US